Comparison between the short‐term outcomes of bevacizumab and ziv‐aflibercept in the treatment of primary diabetic macular oedema

    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.

    loading  Loading Related Articles